Chemoinformaics analysis of COUMARIN-3-CARBOXYLIC-ACID
| Molecular Weight | 190.154 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 13 |
| Exact Molecular Weight | 190.027 | nRing | 2 |
| Solubility: LogS | -2.316 | nHRing | 1 |
| Solubility: LogP | 1.37 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 23.9088 |
| nHD | 1 | BPOL | 9.49124 |
| QED | 0.691 |
| Synth | 1.791 |
| Natural Product Likeliness | -0.215 |
| NR-PPAR-gamma | 0.055 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.043 |
| HIA | 0.008 |
| CACO-2 | -4.903 |
| MDCK | 0.0000154 |
| BBB | 0.142 |
| PPB | 0.813682 |
| VDSS | 0.383 |
| FU | 0.143242 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.096 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.187 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.112 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.063 |
| CL | 1.059 |
| T12 | 0.836 |
| hERG | 0.034 |
| Ames | 0.009 |
| ROA | 0.324 |
| SkinSen | 0.241 |
| Carcinogencity | 0.206 |
| EI | 0.967 |
| Respiratory | 0.078 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.772628 |